Skip to main
ACHC

Acadia Healthcare (ACHC) Stock Forecast & Price Target

Acadia Healthcare (ACHC) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 38%
Buy 23%
Hold 31%
Sell 8%
Strong Sell 0%

Bulls say

Acadia Healthcare Co is a provider of behavioral healthcare services, primarily operating in the United States. The company has seen strong growth in its acute inpatient psychiatric facilities, which contribute the majority of its revenue. Despite some risks to its Medicaid funding and possible regulatory scrutiny, strong volume growth and management's focus on improving cash flow give it a positive outlook. Moreover, the company has raised its 2027 adjusted EBITDA guidance and is actively addressing any operational issues.

Bears say

Acadia Healthcare Co is facing challenges in its operating environment, such as bad debt and denials, which has led to a revision in guidance and increased caution for its stock. While the company has shown improvements in operational efficiency, the stability of its operating environment remains uncertain, leading to a negative outlook. Additionally, there are concerns about the impact of potential Medicaid volume softness and labor headwinds on the company's financial performance. These reasons, combined with a premium valuation in comparison to its peers, suggest that the stock may face challenges in the future.

Acadia Healthcare (ACHC) has been analyzed by 13 analysts, with a consensus rating of Buy. 38% of analysts recommend a Strong Buy, 23% recommend Buy, 31% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Acadia Healthcare (ACHC) Forecast

Analysts have given Acadia Healthcare (ACHC) a Buy based on their latest research and market trends.

According to 13 analysts, Acadia Healthcare (ACHC) has a Buy consensus rating as of Aug 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $29.15, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $29.15, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Acadia Healthcare (ACHC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.